Imophoron

About:

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Website: https://www.imophoron.com/

Twitter/X: imophoron

Top Investors: Global Brain Corporation, Octopus Ventures, SCVC, Jonathan Milner

Description:

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Total Funding Amount:

4M GBP

Headquarters Location:

Bristol, Bristol, City of, United Kingdom

Founded Date:

2017-01-01

Founders:

Frederic Garzoni

Number of Employees:

1-10

Last Funding Date:

2023-07-07

IPO Status:

Private

Industries: